ProShares Ultra QQQ ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? ProShares Ultra QQQ ETF trades at $98.43 (market cap $15.38B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is the larger of the two by market cap, and ProShares Ultra QQQ ETF is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ProShares Ultra QQQ ETF for 36 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| QLD | ROIV | |
|---|---|---|
Market Cap | $15.38B | $24.72B |
Volume | 4,844,085 | 6,279,442 |
Sector | Leveraged / Inverse | Health |
52-Week High | $100.77 | $41.81 |
52-Week Low | $57.16 | $16.04 |
Typical Hold Time | 36 Days | 1 Days |
Enterprise Value | — | $20.99B |
Signals from Pluang's Aura AI — not financial advice
QLD (ProShares Ultra QQQ ETF) trades at $97.56, down 2.66% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The ETF provides 2x leveraged exposure to the Nasdaq-100 index, positioned as a less volatile alternative to triple-leveraged products. Recent institutional buying and media coverage highlight investor interest in leveraged tech exposure amid market uncertainty.
The outlook for QLD hinges on Nasdaq-100 performance, with technical support at $96 and resistance at $100. While leveraged ETFs offer amplified returns, they carry elevated risk during market downturns. Current sentiment is cautiously optimistic, but investors should be aware of decay effects and interest rate sensitivity.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on QLD →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →